These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 806289)

  • 1. A possible role for glass bead immobilized enzymes as therapeutic agents (immobilized uricase as enzyme therapy for hyperuricemia).
    Venter JC; Venter BR; Dixon JE; Kaplan NO
    Biochem Med; 1975 Jan; 12(1):79-91. PubMed ID: 806289
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of precipitating anti-urate oxidase antibodies in urate oxidase-resistant hyperuricemia].
    Mourad G; Cristol JP; Chong G; Andary M; Mion C
    Presse Med; 1984 Nov; 13(42):2585. PubMed ID: 6239266
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperuricemia resistant to urate oxidase. Role of anti-serum urate oxidase precipitating antibodies].
    Sibony G; North ML; Bergerat JP; Lang JM; Oberling F
    Presse Med; 1984 Feb; 13(7):443. PubMed ID: 6230621
    [No Abstract]   [Full Text] [Related]  

  • 4. Immobilization of uricase on protamine bound to glass beads and its application to determination of uric acid.
    Nakamura N; Murayama K; Kinoshita T
    Anal Biochem; 1986 Feb; 152(2):386-90. PubMed ID: 3963371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of immobilized enzymes in automated clinical analysis: determination of uric acid and glucose using immobilized enzymes in column form.
    Endo J; Tabata M; Okada S; Murachi T
    Clin Chim Acta; 1979 Jul; 95(2):411-7. PubMed ID: 527227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and antigenicity of soluble cross-linked enzyme/albumin polymers: Advantages for enzyme therapy.
    Remy MH; Poznansky MJ
    Lancet; 1978 Jul; 2(8080):68-70. PubMed ID: 78296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uricase inhibition in the rat by s-triazines: an animal model for hyperuricemia and hyperuricosuria.
    Johnson WJ; Stavric B; Chartrand A
    Proc Soc Exp Biol Med; 1969 May; 131(1):8-12. PubMed ID: 5770131
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of immobilized enzyme reactors in continuous-flow analyzers for the determination of glucose, urea, and uric acid.
    Chirillo R; Caenaro G; Pavan B; Pin A
    Clin Chem; 1979 Oct; 25(10):1744-8. PubMed ID: 476924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technic of determination of serum allantoin and study of the action of uricase].
    Stahl A; Schang AM; Brogard JM; Coumaros C
    Ann Biol Clin (Paris); 1970; 28(5):377-85. PubMed ID: 5511721
    [No Abstract]   [Full Text] [Related]  

  • 10. Discrete analysis of serum uric acid with immobilized uricase and peroxidase.
    Bhargava AK; Lal H; Pundir CS
    J Biochem Biophys Methods; 1999 May; 39(3):125-36. PubMed ID: 10392568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity-masking delivery of uricase against hyperuricemia and gout.
    Ban Z; Sun M; Ji H; Ning Q; Cheng C; Shi T; He M; Chen X; Lu H; He X; Guo C; He Y; Shao D; He Y
    J Control Release; 2024 Aug; 372():862-873. PubMed ID: 38906421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral uricase eliminates blood uric acid in the hyperuricemic pig model.
    Szczurek P; Mosiichuk N; Woliński J; Yatsenko T; Grujic D; Lozinska L; Pieszka M; Święch E; Pierzynowski SG; Goncharova K
    PLoS One; 2017; 12(6):e0179195. PubMed ID: 28594873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders.
    Lu J; Hou X; Yuan X; Cui L; Liu Z; Li X; Ma L; Cheng X; Xin Y; Wang C; Zhang K; Wang X; Ren W; Sun R; Jia Z; Tian Z; Mi QS; Li C
    Kidney Int; 2018 Jan; 93(1):69-80. PubMed ID: 28729031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low uricase activity in the Dalmatian dog simulated in mongrels given oxonic acid.
    Yü TF; Gutman AB; Berger L; Kaung C
    Am J Physiol; 1971 Apr; 220(4):973-9. PubMed ID: 5551153
    [No Abstract]   [Full Text] [Related]  

  • 15. [Uricolytic therapy. Value of urate oxidase in the treatment of hyperuricemias].
    Potaux L; Aparicio M; Maurel C; Ruedas ME; Martin-Dupont Cl
    Nouv Presse Med; 1975 Apr; 4(15):1109-12. PubMed ID: 1094413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies.
    Pui CH; Relling MV; Lascombes F; Harrison PL; Struxiano A; Mondesir JM; Ribeiro RC; Sandlund JT; Rivera GK; Evans WE; Mahmoud HH
    Leukemia; 1997 Nov; 11(11):1813-6. PubMed ID: 9369411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice.
    Wu X; Wakamiya M; Vaishnav S; Geske R; Montgomery C; Jones P; Bradley A; Caskey CT
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):742-6. PubMed ID: 8290593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo activity of soluble cross-linked uricase-albumin polymers: a model for enzyme therapy.
    Poznansky MJ
    Life Sci; 1979 Jan; 24(2):153-8. PubMed ID: 763074
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the uricase-inhibited rat as an animal model in toxicology.
    Stavric B; Nera EA
    Clin Toxicol; 1978; 13(1):47-74. PubMed ID: 367691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients With leukemia or lymphoma.
    Pui CH; Mahmoud HH; Wiley JM; Woods GM; Leverger G; Camitta B; Hastings C; Blaney SM; Relling MV; Reaman GH
    J Clin Oncol; 2001 Feb; 19(3):697-704. PubMed ID: 11157020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.